These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12418497)

  • 1. Electrophysiological neuroimaging of the central effects of S-adenosyl-L-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography.
    Saletu B; Anderer P; Di Padova C; Assandri A; Saletu-Zyhlarz GM
    Am J Clin Nutr; 2002 Nov; 76(5):1162S-71S. PubMed ID: 12418497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.
    Saletu-Zyhlarz GM; Anderer P; Linzmayer L; Semlitsch HV; Assandri A; Prause W; Hassan Abu-Bakr M; Lindeck-Pozza E; Saletu B
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):199-215. PubMed ID: 12366873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
    Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry.
    Saletu B; Anderer P; Linzmayer L; Semlitsch HV; Lindeck-Pozza E; Assandri A; di Padova C; Saletu-Zyhlarz GM
    J Neural Transm (Vienna); 2002 Dec; 109(12):1505-26. PubMed ID: 12486491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA).
    Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Saletu B; Zeitlhofer J
    Sleep Med; 2009 Sep; 10(8):850-8. PubMed ID: 19342295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials.
    Anderer P; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Pascual-Marqui RD
    Neuropsychobiology; 2004; 49(3):134-53. PubMed ID: 15034229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco-ERP topography and tomography).
    Anderer P; Saletu B; Semlitsch HV; Pascual-Marqui RD
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():121-37. PubMed ID: 12575494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Event-related-potential low-resolution brain electromagnetic tomography (ERP-LORETA) suggests decreased energetic resources for cognitive processing in narcolepsy.
    Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
    Clin Neurophysiol; 2008 Aug; 119(8):1782-1794. PubMed ID: 18571979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrical sources of P300 event-related brain potentials revealed by low resolution electromagnetic tomography. 2. Effects of nootropic therapy in age-associated memory impairment.
    Anderer P; Saletu B; Semlitsch HV; Pascual-Marqui RD
    Neuropsychobiology; 1998; 37(1):28-35. PubMed ID: 9438269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography.
    Anderer P; Saletu B; Wolzt M; Culic S; Assandri A; Nannipieri F; Rosini S; Saletu-Zyhlarz GM
    Hum Psychopharmacol; 2008 Apr; 23(3):243-54. PubMed ID: 18181252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and energetic processes related to P300: LORETA findings in depression and effects of antidepressant drugs.
    Anderer P; Saletu B; Semlitsch HV; Pascual-Marqui RD
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():85-91. PubMed ID: 12575474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multichannel auditory event-related brain potentials: effects of normal aging on the scalp distribution of N1, P2, N2 and P300 latencies and amplitudes.
    Anderer P; Semlitsch HV; Saletu B
    Electroencephalogr Clin Neurophysiol; 1996 Nov; 99(5):458-72. PubMed ID: 9020805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
    Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
    Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
    Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
    Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
    Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of normal aging on sources of standard N1, target N1 and target P300 auditory event-related brain potentials revealed by low resolution electromagnetic tomography (LORETA).
    Anderer P; Pascual-Marqui RD; Semlitsch HV; Saletu B
    Electroencephalogr Clin Neurophysiol; 1998 Mar; 108(2):160-74. PubMed ID: 9566629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrical sources of P300 event-related brain potentials revealed by low resolution electromagnetic tomography. 1. Effects of normal aging.
    Anderer P; Pascual-Marqui RD; Semlitsch HV; Saletu B
    Neuropsychobiology; 1998; 37(1):20-7. PubMed ID: 9438268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain areas and time course of emotional processing.
    Esslen M; Pascual-Marqui RD; Hell D; Kochi K; Lehmann D
    Neuroimage; 2004 Apr; 21(4):1189-203. PubMed ID: 15050547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive effects of topiramate revealed by standardised low-resolution brain electromagnetic tomography (sLORETA) of event-related potentials.
    Jung KY; Cho JW; Joo EY; Kim SH; Choi KM; Chin J; Park KW; Hong SB
    Clin Neurophysiol; 2010 Sep; 121(9):1494-1501. PubMed ID: 20678718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairment.
    Semlitsch HV; Anderer P; Saletu B; Hochmayer I
    Neuropsychobiology; 1990-1991; 24(1):49-56. PubMed ID: 2132641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.